Total Payments
$6,984
2024 Payments
$466.71
Companies
28
Transactions
387
Medicare Patients
321
Medicare Billing
$43,180
Payment Breakdown by Category
Food & Beverage$6,938 (99.3%)
Education$46.91 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,938 | 386 | 99.3% |
| Education | $46.91 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $999.94 | 53 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $945.10 | 45 | $0 (2024) |
| Alkermes, Inc. | $743.23 | 38 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $673.30 | 27 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $581.64 | 33 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $441.50 | 35 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $434.30 | 22 | $0 (2023) |
| ITI, Inc. | $395.75 | 21 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $309.14 | 26 | $0 (2023) |
| Lundbeck LLC | $280.00 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $466.71 | 18 | ABBVIE INC. ($222.17) |
| 2023 | $2,025 | 105 | ABBVIE INC. ($437.93) |
| 2022 | $2,436 | 140 | Alkermes, Inc. ($398.24) |
| 2021 | $2,056 | 124 | Janssen Pharmaceuticals, Inc ($645.73) |
All Payment Transactions
387 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $38.66 | General |
| Category: Neuropsychiatry | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: Neuropsychiatry | ||||||
| 05/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: Neuropsychiatry | ||||||
| 05/01/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.14 | General |
| Category: PSYCHIATRY | ||||||
| 04/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $113.12 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Neuroscience | ||||||
| 04/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Neuropsychiatry | ||||||
| 03/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Neuroscience | ||||||
| 03/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Neuropsychiatry | ||||||
| 02/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Neuropsychiatry | ||||||
| 02/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.46 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: CNS | ||||||
| 12/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Neuropsychiatry | ||||||
| 12/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 104 | 273 | $51,670 | $14,594 |
| 2022 | 2 | 87 | 188 | $26,900 | $9,001 |
| 2021 | 2 | 58 | 197 | $28,200 | $10,758 |
| 2020 | 2 | 72 | 257 | $27,900 | $8,827 |
Total Patients
321
Total Services
915
Medicare Billing
$43,180
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 220 | $43,750 | $12,631 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 53 | $7,920 | $1,963 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 103 | $16,800 | $5,619 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 85 | $10,100 | $3,382 | 33.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 170 | $25,500 | $10,203 | 40.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 27 | $2,700 | $554.79 | 20.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 61 | 246 | $24,600 | $7,847 | 31.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 11 | 11 | $3,300 | $980.12 | 29.7% |
About Lula Thomas
Lula Thomas is a Nurse Practitioner healthcare provider based in Moosic, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2013. The National Provider Identifier (NPI) number assigned to this provider is 1245668177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lula Thomas has received a total of $6,984 in payments from pharmaceutical and medical device companies, with $466.71 received in 2024. These payments were reported across 387 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($6,938).
As a Medicare-enrolled provider, Thomas has provided services to 321 Medicare beneficiaries, totaling 915 services with total Medicare billing of $43,180. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Moosic, PA
- Active Since 11/01/2013
- Last Updated 11/01/2013
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1245668177
Products in Payments
- VRAYLAR (Drug) $1,013
- INGREZZA (Drug) $673.30
- REXULTI (Drug) $576.93
- ARISTADA (Drug) $568.09
- INVEGA SUSTENNA (Drug) $491.30
- SPRAVATO (Drug) $453.80
- TRINTELLIX (Drug) $441.50
- CAPLYTA (Drug) $395.75
- AUSTEDO (Drug) $361.48
- QELBREE (Drug) $309.14
- HETLIOZ (Drug) $187.75
- Auvelity (Drug) $151.96
- ABILIFY MAINTENA (Drug) $137.37
- UZEDY (Drug) $121.85
- APLENZIN (Drug) $102.12
- SECUADO (Drug) $101.94
- Austedo XR (Drug) $98.31
- Azstarys (Drug) $91.50
- BELSOMRA (Drug) $89.35
- LYBALVI (Drug) $82.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.